Cryoport, Inc. splits its revenue 2 ways in its filings. By operating segments, the largest line in fiscal 2025, which ended Dec 31, 2025 was Life Sciences Services at $101.0 million, 57% of the total. By sales mix, the largest line in fiscal 2025, which ended Dec 31, 2025 was Product at $79.7 million, 45% of the total.
USD in millions. The percent under a figure is the change from the year before.
| Line |
FY 2026
Sep 30, 2026
|
FY 2025
Dec 31, 2025
|
FY 2024
Dec 31, 2024
|
FY 2023
Dec 31, 2023
|
FY 2022
Dec 31, 2022
|
FY 2020
Dec 31, 2021
|
FY 2020
Dec 31, 2020
|
FY 2019
Dec 31, 2019
|
FY 2018
Dec 31, 2018
|
FY 2017
Dec 31, 2017
|
FY 2016
Mar 31, 2016
|
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
192
|
176
|
157
|
169
|
237
|
223
|
79
|
34
|
20
|
12
|
6
|
| Operating segments | |||||||||||
| Life Sciences Services |
—
|
101
+18.4%
share 57.3%
|
85
+5.1%
share 54.4%
|
81
share 48.1%
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
| Life Sciences Products |
—
|
75
+5.2%
share 42.7%
|
71
-18.3%
share 45.6%
|
87
-14.3%
share 51.9%
|
102
share 43.0%
|
—
|
—
|
—
|
—
|
—
|
—
|
| Sales mix | |||||||||||
| Product |
—
|
80
+6.6%
share 45.2%
|
75
-16.2%
share 47.7%
|
89
-13.8%
share 52.9%
|
103
share 43.6%
|
104
share 46.5%
|
23
share 29.7%
|
—
|
—
|
—
|
—
|
| Biologistics Solutions |
—
|
78
+16.6%
share 44.4%
|
67
+1.7%
share 42.8%
|
66
-47.2%
share 39.1%
|
125
share 52.6%
|
—
|
—
|
—
|
—
|
—
|
—
|
| Biostorage Bioservices |
—
|
18
+22.2%
share 10.4%
|
15
+10.6%
share 9.6%
|
14
+49.6%
share 8.1%
|
9
share 3.8%
|
—
|
—
|
—
|
—
|
—
|
—
|
How these figures are calculated
Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions. Each group is a separate split of total revenue, so the groups are not added together. Share of revenue is that line divided by total revenue. The first column adds the latest year-to-date segment amount to the last fiscal year and subtracts the year-ago year-to-date amount. More on our methodology.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- CYRX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- NV
- Headquarters
- Brentwood, TN
- SEC filer status
- Accelerated filer
- SEC CIK
- 1124524
- Former names
- CRYOPORT SYSTEMS INC (until Oct 20, 2005)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.